Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia

被引:21
作者
Genesca, E. [1 ,21 ]
Lazarenkov, A. [1 ]
Morgades, M. [2 ]
Berbis, G. [1 ]
Ruiz-Xiville, N. [2 ]
Gomez-Marzo, P. [1 ]
Ribera, J. [1 ]
Junca, J. [2 ]
Gonzalez-Perez, A. [3 ]
Mercadal, S. [4 ]
Guardia, R. [5 ]
Artola, M. T. [6 ]
Moreno, M. J. [7 ]
Martinez-Lopez, J. [8 ]
Zamora, L. [2 ]
Barba, P. [9 ]
Gil, C. [10 ]
Tormo, M. [11 ]
Cladera, A. [12 ]
Novo, A. [13 ]
Pratcorona, M. [14 ]
Nomdedeu, J. [14 ]
Gonzalez-Campos, J. [15 ]
Almeida, M. [16 ]
Cervera, J. [17 ]
Montesinos, P. [18 ]
Batlle, M. [2 ]
Vives, S. [2 ]
Esteve, J. [19 ]
Feliu, E. [1 ]
Sole, F. [1 ]
Orfao, A. [20 ]
Ribera, J. M. [2 ]
机构
[1] UAB, Josep Carreras Leukaemia Res Inst IJC, Campus ICO Germans Trias & Pujol, Badalona, Spain
[2] UAB, ICO Hosp Germans Trias & Pujol, Clin Hematol Dept, Campus ICO Germans Trias & Pujol, Badalona, Spain
[3] Univ Pompeu Fabra, Res Program Biomed Informat, Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain
[4] Hosp Duran & Reynals ICO, Clin Hematol Serv, Barcelona, Spain
[5] Hosp Josep Trueta ICO, Clin Hematol Serv, Girona, Spain
[6] Hosp Univ Donostia, Clin Hematol Serv, Donostia San Sebastian, Spain
[7] Hosp Virgen Victoria, Clin Hematol Serv, Malaga, Spain
[8] Univ Complutense, CNIO, Hosp Octubre 12, Hematol Dept, Madrid, Spain
[9] Hosp Univ Vall dHebron, Clin Hematol Serv, Barcelona, Spain
[10] Hosp Gen Alicante, Clin Hematol Serv, Alicante, Spain
[11] Hosp Clin Valencia, Clin Hematol Serv, Valencia, Spain
[12] Hosp Son Llatzer, Clin Hematol Serv, Palma De Mallorca, Spain
[13] Hosp Son Espases, Clin Hematol Serv, Palma De Mallorca, Spain
[14] Hosp Santa Creu & Sant Pau, Clin Hematol Serv, Barcelona, Spain
[15] Hosp Virgen Rocio, Clin Hematol Serv, Seville, Spain
[16] Univ Salamanca, Banco Nacl ADN Carlos III, Salamanca, Spain
[17] Inst Invest Sanit La Fe IIS La Fe, Biobanco La Fe, Valencia, Spain
[18] Hosp La Fe, Clin Hematol Serv, Valencia, Spain
[19] Hosp Clin Barcelona, Clin Hematol Serv, Barcelona, Spain
[20] Hosp Clin Univ Salamanca HUS, Inst Biosanit Salamanca IBSAL, CIC, IBMCC CSIC USAL,CIBERONC, Salamanca, Spain
[21] Josep Carreras Leukaemia Res Inst IJC, ALL Res Grp, Cami Escoles S-N,Edifici IJC, Badalona 08916, Spain
关键词
T-ALL; CDKN2A/ARF; CDKN2B; Prognosis; MRD; MINIMAL RESIDUAL DISEASE;
D O I
10.1186/s13045-018-0639-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recurrent deletions of the CDKN2A/ARF/CDKN2B genes encoded at chromosome 9p21 have been described in both pediatric and adult acute lymphoblastic leukemia (ALL), but their prognostic value remains controversial, with limited data on adult T-ALL. Here, we investigated the presence of homozygous and heterozygous deletions of the CDKN2A/ARF and CDKN2B genes in 64 adult T-ALL patients enrolled in two consecutive trials from the Spanish PETHEMA group. Alterations in CDKN2A/ARF/CDKN2B were detected in 35/64 patients (55%). Most of them consisted of 9p21 losses involving homozygous deletions of the CDKNA/ARF gene (26/64), as confirmed by single nucleotide polymorphism (SNP) arrays and interphase fluorescence in situ hybridization (iFISH). Deletions involving the CDKN2A/ARF/CDKN2B locus correlated with a higher frequency of cortical T cell phenotype and a better clearance of minimal residual disease (MRD) after induction therapy. Moreover, the combination of an altered copy-number-value (CNV) involving the CDKN2A/ARF/CDKN2B gene locus and undetectable MRD (<= 0.01%) values allowed the identification of a subset of T-ALL with better overall survival in the absence of hematopoietic stem cell transplantation.
引用
收藏
页数:4
相关论文
共 10 条
[1]   Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia [J].
Beldjord, Kheira ;
Chevret, Sylvie ;
Asnafi, Vahid ;
Huguet, Francoise ;
Boulland, Marie-Laure ;
Leguay, Thibaut ;
Thomas, Xavier ;
Cayuela, Jean-Michel ;
Grardel, Nathalie ;
Chalandon, Yves ;
Boissel, Nicolas ;
Schaefer, Beat ;
Delabesse, Eric ;
Cave, Helene ;
Chevallier, Patrice ;
Buzyn, Agnes ;
Fest, Thierry ;
Reman, Oumedaly ;
Vernant, Jean-Paul ;
Lheritier, Veronique ;
Bene, Marie C. ;
Lafage, Marina ;
Macintyre, Elizabeth ;
Ifrah, Norbert ;
Dombret, Herve .
BLOOD, 2014, 123 (24) :3739-3749
[2]  
BENE MC, 1995, LEUKEMIA, V9, P1783
[3]   CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia [J].
Bertin, R ;
Acquaviva, C ;
Mirebeau, D ;
Guidal-Giroux, C ;
Vilmer, E ;
Cavé, H .
GENES CHROMOSOMES & CANCER, 2003, 37 (01) :44-57
[4]   Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study [J].
Borowitz, Michael J. ;
Devidas, Meenakshi ;
Hunger, Stephen P. ;
Bowman, W. Paul ;
Carroll, Andrew J. ;
Carroll, William L. ;
Linda, Stephen ;
Martin, Paul L. ;
Pullen, D. Jeanette ;
Viswanatha, David ;
Willman, Cheryl L. ;
Winick, Naomi ;
Camitta, Bruce M. .
BLOOD, 2008, 111 (12) :5477-5485
[5]   Genetic Basis of Acute Lymphoblastic Leukemia [J].
Iacobucci, Ilaria ;
Mullighan, Charles G. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (09) :975-983
[6]   The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia [J].
Liu, Yu ;
Easton, John ;
Shao, Ying ;
Maciaszek, Jamie ;
Wang, Zhaoming ;
Wilkinson, Mark R. ;
McCastlain, Kelly ;
Edmonson, Michael ;
Pounds, Stanley B. ;
Shi, Lei ;
Zhou, Xin ;
Ma, Xiaotu ;
Sioson, Edgar ;
Li, Yongjin ;
Rusch, Michael ;
Gupta, Pankaj ;
Pei, Deqing ;
Cheng, Cheng ;
Smith, Malcolm A. ;
Auvil, Jaime Guidry ;
Gerhard, Daniela S. ;
Relling, Mary V. ;
Winick, Naomi J. ;
Carroll, Andrew J. ;
Heerema, Nyla A. ;
Raetz, Elizabeth ;
Devidas, Meenakshi ;
Willman, Cheryl L. ;
Harvey, Richard C. ;
Carroll, William L. ;
Dunsmore, Kimberly P. ;
Winter, Stuart S. ;
Wood, Brent L. ;
Sorrentino, Brian P. ;
Downing, James R. ;
Loh, Mignon L. ;
Hunger, Stephen P. ;
Zhang, Jinghui ;
Mullighan, Charles G. .
NATURE GENETICS, 2017, 49 (08) :1211-+
[7]   Probe-Based Quantitative PCR Assay for Detecting Constitutional and Somatic Deletions in the NF1 Gene: Application to Genetic Testing and Tumor Analysis [J].
Terribas, Ernest ;
Garcia-Linares, Carles ;
Lazaro, Conxi ;
Serra, Eduard .
CLINICAL CHEMISTRY, 2013, 59 (06) :928-937
[8]   Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia [J].
Theunissen, Prisca ;
Mejstrikova, Ester ;
Sedek, Lukasz ;
van der Sluijs-Gelling, Alita J. ;
Gaipa, Giuseppe ;
Bartels, Marius ;
da Costa, Elaine Sobral ;
Kotrova, Michaela ;
Novakova, Michaela ;
Sonneveld, Edwin ;
Buracchi, Chiara ;
Bonaccorso, Paola ;
Oliveira, Elen ;
te Marvelde, Jeroen G. ;
Szczepanski, Tomasz ;
Lhermitte, Ludovic ;
Hrusak, Ondrej ;
Lecrevisse, Quentin ;
Emilia Grigore, Georgiana ;
Fronkova, Eva ;
Trka, Jan ;
Brueggemann, Monika ;
Orfao, Alberto ;
van Dongen, Jacques J. M. ;
van der Velden, Vincent H. J. .
BLOOD, 2017, 129 (03) :347-357
[9]   Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients [J].
Toubai, T ;
Tanaka, J ;
Ota, S ;
Fukuhara, T ;
Hashino, S ;
Kondo, T ;
Kasai, M ;
Kakinoki, Y ;
Masauzi, N ;
Morioka, M ;
Kawamura, T ;
Iwasaki, H ;
Asaka, M ;
Imamura, M .
AMERICAN JOURNAL OF HEMATOLOGY, 2005, 80 (03) :181-187
[10]   Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors [J].
Zuurbier, Linda ;
Gutierrez, Alejandro ;
Mullighan, Charles G. ;
Cante-Barrett, Kirsten ;
Gevaert, A. Olivier ;
de Rooi, Johan ;
Li, Yunlei ;
Smits, Willem K. ;
Buijs-Gladdines, Jessica G. C. A. M. ;
Sonneveld, Edwin ;
Look, A. Thomas ;
Horstmann, Martin ;
Pieters, Rob ;
Meijerink, Jules P. P. .
HAEMATOLOGICA, 2014, 99 (01) :94-102